Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Gheorghiade, M.
Right arrow Articles by Zannad, F.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Gheorghiade, M.
Right arrow Articles by Zannad, F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2005. All rights reserved. For Permissions, please e-mail: journals.permissions{at}oupjournals.org

Modern management of acute heart failure syndromes

Mihai Gheorghiade1,* and Faiez Zannad2,3,4

1Division of Cardiology, Northwestern University Feinberg School of Medicine, Galter 10-240, 201 E. Huron Street, Chicago, IL 60611, USA
2INSERM, Centre d'investigation clinique CIC-INSERM CHU, Hôpital Jeanne d'Arc, 54200 Dommartin les Toul, Nancy, France
3CHU, Département des Maladies Cardio-Vasculaires, Nancy, France
4Université Henri Poincaré, Nancy, France

* Corresponding author. E-mail address: m-gheorghiade{at}northwestern.edu

Heart failure is an important and growing public health problem throughout the developed world. Clinical interest has recently focused on acute heart failure syndromes (AHFS), which make a major contribution to the substantial financial and humanistic burden of disease. Despite the undoubted clinical importance of AHFS, no universally accepted definition of the condition exists and the first treatment guidelines remain to be published. The prognosis for patients with AHFS remains poor. Many acute therapeutic interventions are yet to be validated in randomized controlled trials, although recent years have seen a number of large-scale studies and the introduction of several new treatment options. In contrast to AHFS, substantial progress has been made in developing management strategies for chronic heart failure, although use of well-established life-saving therapies remains suboptimal. A brief introduction to the current key issues in AHFS, which are discussed in more detail in this supplement, is provided in this paper.

Key Words: Acute disease • Congestive heart failure, classification/pathophysiology/mortality/therapy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.